POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could ease painful muscle condition and cut steroid use
Disease control OngoingThis phase 3 trial tests a biologic drug called olokizumab in 125 people with polymyalgia rheumatica, a condition causing muscle pain and stiffness. The drug is given as a shot every two weeks. The main goal is to see if it can control symptoms and allow patients to take lower do…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: R-Pharm International, LLC • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for PMR patients: Long-Term safety trial of secukinumab underway
Disease control OngoingThis study is testing the long-term safety of secukinumab, a biologic drug, in people with polymyalgia rheumatica (PMR). It includes 161 patients who already completed a 52-week study of secukinumab and had a relapse after stopping treatment. The main goal is to see how safe and …
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a single drug free PMR patients from steroids?
Disease control OngoingThis phase 3 trial tests whether rituximab, a drug that calms certain immune cells, can help people with polymyalgia rheumatica (PMR) stop taking steroids without their symptoms returning. The study includes 174 adults who are currently experiencing a PMR relapse and cannot lower…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New taper strategy aims to free PMR patients from Long-Term steroids
Disease control OngoingThis study tests whether a nurse-led, step-by-step plan to slowly reduce prednisolone (a steroid) helps people with polymyalgia rheumatica stop the drug safely and stay in remission. About 120 newly diagnosed patients will either follow this structured taper or receive usual care…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New imaging methods could transform PMR diagnosis
Diagnosis OngoingThis study explores whether ultrasound and PET/CT scans can more accurately diagnose and monitor polymyalgia rheumatica (PMR), a condition causing muscle pain and inflammation. Researchers will follow 98 adults over 50 suspected of having PMR, using imaging at key points during t…
Matched conditions: POLYMYALGIA RHEUMATICA
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingThis study aims to create a tool that predicts which patients with inflammatory rheumatic diseases (like rheumatoid arthritis, vasculitis, or polymyalgia rheumatica) will develop serious side effects from long-term steroid use. Researchers will collect routine medical data—such a…
Matched conditions: POLYMYALGIA RHEUMATICA
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC